GC Biopharma, Hanmi Seal Fabry Drug Deal
Predicted impact: Medium
Up to ₩650B Fabry/BioMarin deal, about 42% of market value, already reported in the last 14 days.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.